|
1
|
Harris RE: Cyclooxygenase-2 (cox-2)
blockade in the chemoprevention of cancers of the colon, breast,
prostate, and lung. Inflammopharmacology. 17:1–13. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Harris RE, Casto BC and Harris ZM:
Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J
Clin Oncol. 5:677–692. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Steele VE, Holmes CA, Hawk ET, Kopelovich
L, Lubet RA, Crowell JA, Sigman CC and Kelloff GJ: Lipoxgenase
inhibitors as potential cancer chemopreventives. Cancer Epidemiol
Biomarkers Prev. 8:467–483. 1999.PubMed/NCBI
|
|
4
|
Wang D and Dubois RN: Eicosanoids and
cancer. Nat Rev Cancer. 10:181–193. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Schneider C and Pozzi A: Cyclooxygenases
and lipoxygenases in cancer. Cancer Metastasis Rev. 30:277–294.
2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wisastra R and Dekker FJ: Inflammation,
cancer and oxidative lipoxygenase activity are intimately linked.
Cancers (Basel). 6:1500–1521. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kennedy BM and Harris RE: Cyclooxygenase
and lipoxygenase gene expression in the inflammogenesis of breast
cancer. Inflammopharmacology. 26:909–923. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tsai MJ, Wu PH, Sheu CC, Hsu YL, Chang WA,
Hung JY, Yang CJ, Yang YH, Kuo PL and Huang MS: Cysteinyl
leukotriene receptor antagonists decrease cancer risk in asthma
patients. Sci Rep. 7(23979)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Schlesselman JJ: Case control studies.
Oxford University Press, New York, NY, 1982.
|
|
10
|
Harrell F: Logistic regression procedure.
Statistical Analysis System (SAS), 2005.
|
|
11
|
Jiang WG, Douglas-Jones AG and Mansel RE:
Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP)
has prognostic and survival significance in patients with breast
cancer. Prostaglandins Leukot Essent Fatty Acids. 74:125–134.
2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang J, John EM and Ingles SA:
5-lipoxygenase and 5-lipoxygenase-activating protein gene
polymorphisms, dietary linoleic acid, and risk for breast cancer.
Cancer Epidemiol Biomarkers Prev. 17:2748–2754. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Choi JA, Lee JW, Kim H, Kim EY, Seo JM, Ko
J and Kim JH: Pro-survival of estrogen receptor-negative breast
cancer cells is regulated by a BLT2-reactive oxygen species-linked
signaling pathway. Carcinogenesis. 31:543–551. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kim H, Choi JA, Park GS and Kim JH: BLT2
up-regulates interleukin-8 production and promotes the invasiveness
of breast cancer cells. PLoS One. 7(e49186)2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Haeggström JZ and Funk CD: Lipoxygenase
and leukotriene pathways: Biochemistry, biology, and roles in
disease. Chem Rev. 111:5866–5898. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jiang WG, Douglas-Jones A and Mansel RE:
Levels of expression of lipoxygenases and cyclooxygenase-2 in human
breast cancer. Prostaglandins Leukot Essent Fatty Acids.
69:275–281. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Soumaoro LT, Iida S, Uetake H, Ishiguro M,
Takagi Y, Higuchi T, Yasuno M, Enomoto M and Sugihara K: Expression
of 5-lipoxygenase in human colorectal cancer. World J
Gastroenterol. 12:6355–6360. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kleinstein SE, Heath L, Makar KW, Poole
EM, Seufert BL, Slattery ML, Xiao L, Duggan DJ, Hsu L, Curtin K, et
al: Genetic variation in the lipoxygenase pathway and risk of
colorectal neoplasia. Genes Chromosomes Cancer. 52:437–449.
2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ghosh J and Myers CE: Arachidonic acid
stimulates prostate cancer cell growth: Critical role of
5-lipoxygenase. Biochem Biophys Res Commun. 235:418–423.
1997.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rocconi RP, Kirby TO, Seitz RS, Beck R,
Straughn JM Jr, Alvarez RD and Huh WK: Lipoxygenase pathway
receptor expression in ovarian cancer. Reprod Sci. 15:321–326.
2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Faronato M, Muzzonigro G, Milanese G,
Menna C, Bonfigli AR, Catalano A and Procopio A: Increased
expression of 5-lipoxygenase is common in clear cell renal cell
carcinoma. Histol Histopathol. 22:1109–1118. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tong WG, Ding XZ, Talamonti MS, Bell RH
and Adrian TE: LTB4 stimulates growth of human pancreatic cancer
cells via MAPK and PI-3 kinase pathways. Biochem Biophys Res
Commun. 335:949–956. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hennig R, Grippo P, Ding XZ, Rao SM,
Buchler MW, Friess H, Talamonti MS, Bell RH and Adrian TE:
5-Lipoxygenase, a marker for early pancreatic intraepithelial
neoplastic lesions. Cancer Res. 65:6011–6016. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen X, Wang S, Wu N, Sood S, Wang P, Jin
Z, Beer DG, Giordano TJ, Lin Y, Shih WC, et al: Overexpression of
5-lipoxygenase in rat and human esophageal adenocarcinoma and
inhibitory effects of zileuton and celecoxib on carcinogenesis.
Clin Cancer Res. 10:6703–6709. 2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sveinbjörnsson B, Rasmuson A, Baryawno N,
Wan M, Pettersen I, Ponthan F, Orrego A, Haeggström JZ, Johnsen JI
and Kogner P: Expression of enzymes and receptors of the
leukotriene pathway in human neuroblastoma promotes tumor survival
and provides a target for therapy. FASEB J. 22:3525–3536.
2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Rioux N and Castonguay A: Inhibitors of
lipoxygenase: A new class of cancer chemopreventive agents.
Carcinogenesis. 19:1393–1400. 1998.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mashima R and Okuyama T: The role of
lipoxygenases in pathophysiology: New insights and future
perspectives. Redox Biol. 6:297–310. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Moore GY and Pidgeon GP: Cross-talk
between cancer cells and the tumour microenvironment: The role of
the 5-lipoxygenase pathway. Int J Molecular Sciences.
18(236)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhao S, Yao K, Li D, Liu K, Jin G, Yan M,
Wu Q, Chen H, Shin SH, Bai R, et al: Inhibition of LTA4H by
bestatin in human and mouse colorectal cancer. EBioMedicine.
44:361–374. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Harris RE, Beebe-Donk J and Alshafie GA:
Reduction in the risk of human breast cancer by selective
cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer.
6(27)2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lowcock EC, Cotterchio M and Ahmad N:
Association between allergies, asthma, and breast cancer risk among
women in Ontario, Canada. Cancer Causes Control. 24:1053–1056.
2013.PubMed/NCBI View Article : Google Scholar
|
